Using an Endogenous CRISPR-Cas System for Genome Editing in the Human Pathogen Clostridium difficile

Area of Science:

• Microbiology
• Genetics
• Molecular Biology

Background:

• Clostridium difficile is a major cause of healthcare-associated diarrhea in industrialized nations.
• Understanding C. difficile pathophysiology and host adaptation is crucial but limited by available genetic tools.
• C. difficile possesses an active CRISPR-Cas system (subtype I-B) for defense against foreign DNA, potentially aiding its survival.

Purpose of the Study:

• To develop a novel genome editing method for C. difficile by repurposing its endogenous CRISPR-Cas system.
• To demonstrate the efficiency of this new genome editing approach in key C. difficile strains.
• To expand the limited genetic engineering toolkit for C. difficile research.

Main Methods:

• Redirecting the endogenous CRISPR-Cas system of C. difficile towards autoimmunity.
• Applying the engineered system for targeted gene deletion.
• Testing the method in reference strain 630Δerm and epidemic strain R20291.

Main Results:

• Demonstrated efficient genome editing in C. difficile by hijacking the CRISPR-Cas system.
• Successfully deleted a specific gene in both reference and epidemic C. difficile strains.
• Established a proof-of-principle for a new, powerful genome editing tool.

Conclusions:

• Repurposing the C. difficile CRISPR-Cas system provides an effective method for genome editing.
• This novel tool significantly enhances the capacity for genetic manipulation in C. difficile.
• The developed CRISPR-Cas based genome editing holds promise for future therapeutic strategies against C. difficile infections.